Potomac Capital Management’s Altimmune ALT Stock Holding History

Potomac Capital Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$786K	Hold	1,970	–	–	0.97%	37
2015 Q2	$1.06M	Sell	1,970 -144	-7%	-$72.8K	1.3%	27
2015 Q1	$1.03M	Sell	2,114 -18	-0.8%	-$8.97K	1.11%	29
2014 Q4	$1.16M	Sell	2,132 -12	-0.6%	-$6.16K	1.34%	27
2014 Q3	$1.15M	Sell	2,144 -158	-7%	-$82.6K	1.25%	31
2014 Q2	$974K	Buy	2,302 +333	+17%	+$151K	0.77%	33
2014 Q1	$1.08M	Buy	1,969 +84	+4%	+$49.1K	0.92%	25
2013 Q4	$1.05M	Buy	+1,885	New	+$1.12M	0.89%	24

Other funds holding ALT

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Potomac Capital Management's ALT Position: Q3 2015 in Review

Potomac Capital Management held its Altimmune (ALT) position steady in Q3 2015 at 1,970 shares worth $786K. The position accounts for 0.97% of the portfolio, ranked #37.

Potomac Capital Management first reported a position in ALT in Q4 2013 and has held it in 8 quarters since. The position peaked at $1.16M in Q4 2014. 32 funds tracked by Wall St. Rank hold ALT as of Q3 2015.

Potomac Capital Management held 1,970 shares of Altimmune worth $786K as of Q3 2015.
Potomac Capital Management left its Altimmune share count unchanged in Q3 2015.
Altimmune made up 0.97% of Potomac Capital Management's portfolio in Q3 2015, its #37 holding.
Potomac Capital Management first reported a position in Altimmune in Q4 2013 and has held it in 8 quarters since.
Potomac Capital Management's Altimmune position peaked at $1.16M in Q4 2014.
32 funds tracked by Wall St. Rank held Altimmune as of Q3 2015.

Based on Potomac Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.